Letters archive
Join the conversation in New Scientist's Letters section, where readers can share their thoughts and opinions on articles and see responses from experts and enthusiasts across a range of science topics. To submit a letter, please see our terms and email letters@newscientist.com
22 April 2009
From Raphael Fraser, Blacktown Hospital
Chris Callaghan wonders whether it is the anaesthetic used in electroconvulsive therapy (ECT) that is responsible for any beneficial effects the treatment may have (21 March, p 23) . ECT has long been controversial. As a psychiatrist I can attest that its benefits are not "occasional": ECT is the most effective antidepressant treatment we know. …
22 April 2009
From Tony Waldron, University College London
Charles Shepherd asks for an objective position to be taken on the aetiology of myalgic encephalomyelitis (ME) (4 April, p 22) . Why are those who support ME reluctant to accept a psychological basis in some cases? In my experience, the response from a patient to such a suggestion is either to say "I'm not …